Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Tinklenberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Translational Medicine|September 5, 2024
AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in miceMonika Chauhan, Audrey L Daugherty, Fatemeh Ellie Khadir, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 2019
Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO MouseJennifer A Tinklenberg, Emily M Siebers, Margaret J Beatka, et al.
Molecular Therapy. Advances|May 15, 2026
Design and initial characterization of a novel mini-promoter for gene therapies targeting the central nervous systemMonika Chauhan, Audrey L Daugherty, Fatemeh Ellie Khadir, et al.
The American Journal of Pathology|October 2, 2025
The D2.B10-Dmd<sup>mdx</sup>/J Mouse Model of Duchenne Muscular Dystrophy Exhibits a Severe Mitochondrial Deficiency Not Observed in the C57BL/10ScSn-Dmd<sup>mdx</sup>/J MouseJennifer A Tinklenberg, Jessica Sutton, Rebecca A Slick, et al.
Human Molecular Genetics|January 3, 2018
Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy miceJennifer A Tinklenberg, Emily M Siebers, Margaret J Beatka, et al.
Biology Open|August 19, 2024
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophyRebecca A Slick, Jessica Sutton, Margaret Haberman, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2018
Sdha+/- Rats Display Minimal Muscle Pathology Without Significant Behavioral or Biochemical AbnormalitiesEmily M Siebers, Melinda J Choi, Jennifer A Tinklenberg, et al.
The American Journal of Pathology|July 8, 2023
Aberrations in Energetic Metabolism and Stress-Related Pathways Contribute to Pathophysiology in the Neb Conditional Knockout Mouse Model of Nemaline MyopathyRebecca A Slick, Jennifer A Tinklenberg, Jessica Sutton, et al.
The American Journal of Pathology|July 7, 2023
Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial BiologyJennifer A Tinklenberg, Rebecca A Slick, Jessica Sutton, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|September 5, 2024
AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in miceMonika Chauhan, Audrey L Daugherty, Fatemeh Ellie Khadir, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 2019
Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO MouseJennifer A Tinklenberg, Emily M Siebers, Margaret J Beatka, et al.
Molecular Therapy. Advances|May 15, 2026
Design and initial characterization of a novel mini-promoter for gene therapies targeting the central nervous systemMonika Chauhan, Audrey L Daugherty, Fatemeh Ellie Khadir, et al.
The American Journal of Pathology|October 2, 2025
The D2.B10-Dmd<sup>mdx</sup>/J Mouse Model of Duchenne Muscular Dystrophy Exhibits a Severe Mitochondrial Deficiency Not Observed in the C57BL/10ScSn-Dmd<sup>mdx</sup>/J MouseJennifer A Tinklenberg, Jessica Sutton, Rebecca A Slick, et al.
Human Molecular Genetics|January 3, 2018
Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy miceJennifer A Tinklenberg, Emily M Siebers, Margaret J Beatka, et al.
Biology Open|August 19, 2024
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophyRebecca A Slick, Jessica Sutton, Margaret Haberman, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2018
Sdha+/- Rats Display Minimal Muscle Pathology Without Significant Behavioral or Biochemical AbnormalitiesEmily M Siebers, Melinda J Choi, Jennifer A Tinklenberg, et al.
The American Journal of Pathology|July 8, 2023
Aberrations in Energetic Metabolism and Stress-Related Pathways Contribute to Pathophysiology in the Neb Conditional Knockout Mouse Model of Nemaline MyopathyRebecca A Slick, Jennifer A Tinklenberg, Jessica Sutton, et al.
The American Journal of Pathology|July 7, 2023
Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial BiologyJennifer A Tinklenberg, Rebecca A Slick, Jessica Sutton, et al.
Pageof 1